Back to News
Market Impact: 0.15
RFK Jr.’s Peptide Plan Makes Compounders Report Side Effects
Source: Bloomberg
Regulation & LegislationHealthcare & Biotech
The White House is reviewing a proposal to broaden access to peptides that includes more patient protections than initially expected, according to people familiar with the matter. The proposal remains under review; no final policy change or timing was reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- SK Hynix shares slide after chipmaker scraps Solidigm IPO plans
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Musk's clash with Ukraine accelerates demand for Starlink alternatives. Few exist
- U.S. propses tighter rules on investments in Chinese tech sectors
- Trump invokes Cold War era Defense Production Act for oil production, refining